Article
Guanine nucleotide‐binding protein 1 is one of the key molecules contributing to cancer cell radioresistance
5 Aug 2014
Abstract excerpt
Standard fractionated radiotherapy for the treatment of cancer consists of daily irradiation of 2-Gy X-rays, 5 days a week for 5-8 weeks. To understand the characteristics of radioresistant cancer cells and to develop more effective radiotherapy, we established a series of novel, clinically relevant radioresistant (CRR) cells that continue to proliferate with 2-Gy X-ray exposure every 24 h for more than 30 days...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
